EF Hutton Initiates Coverage On Kairos Pharma With Buy Rating, Announces Price Target of $9
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
72553206 : that would be nuts, I'm in the long hold. Sadly at $2.2/share